INSULET CORP (PODD)
US45784P1012 - Common Stock
Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options
Insulet to Present at Upcoming Investor Conferences
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Gapping S&P500 stocks in Thursday's session
Comparing Litecoin Versus Insulet Reveals New High
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.
S&P 500 Movers: AKAM, AXON
High growth, ROE and relative strength for NASDAQ:PODD, growth investors may appreciate this.
Evaluating INSULET CORP (NASDAQ:PODD) for Growth Investment Opportunities.
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
Noteworthy Monday Option Activity: PODD, STZ, SJM
Why NASDAQ:PODD qualifies as a high growth stock.
Is INSULET CORP (NASDAQ:PODD) suited for high growth investing?
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
Omnipod® 5 App for iPhone® Now Fully Available in the United States
Noteworthy Wednesday Option Activity: PODD, STNG, ORCL
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
Dynatrace Larger Than S&P 500 Component Insulet
National Campaign Launches to Combat Diabetes Stigma Using Comedy
/PRNewswire/ -- The Spoonful of Laughter campaign is a national initiative using comedy to educate about diabetes, counter harmful stereotypes and stigma, and...
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
Why Insulet Stock Was Zooming Higher This Week
The company had encouraging news to impart about its leading insulin pump.
Wednesday Sector Leaders: Utilities, Healthcare
S&P 500 Movers: SMCI, PODD